Clinical Trial Update: Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating acalabrutinib with bendamustine/rituximab followed by cytarabine/rituximab in untreated mantle cell lymphoma. The study has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CALQUENCE (ACALABRUTINIB)
• CYTARABINE (CYTARABINE)
• Rituxan (rituximab)
• Treanda (Bendamustine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2021-02-02